Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials

Published:2017-07-05 Issue:8 Volume:15 Page:1547-1558
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Laporte S.¹²,Chapelle C.²,Bertoletti L.¹³,Ollier E.¹⁴,Zufferey P.¹⁵,Lega J.-C.⁶⁷,Merah A.⁸,Décousus H.⁸,Schulman S.⁹,Meyer G.¹⁰,Cucherat M.⁷,Mismetti P.¹²

Affiliation:

1. SAINBIOSE U1059; Université Jean Monnet; Université de Lyon; INSERM; Saint-Etienne France

2. Unité de Recherche Clinique, Innovation, Pharmacologie; CHU Saint-Etienne; Hôpital Nord; Saint-Etienne France

3. Service de Médecine Vasculaire et Thérapeutique; CHU Saint-Etienne; Hôpital Nord; Saint-Etienne France

4. Laboratoire de Pharmacologie, Toxicologie et Gaz du sang; CHU Saint-Etienne; Hôpital Nord; Saint-Etienne France

5. Unité de Recherche Clinique Innovation, Pharmacologie, and Service d'Anesthésie Réanimation; CHU Saint-Etienne; Hôpital Nord; Saint-Etienne France

6. Département de Médecine Interne et Pathologie Vasculaire; Hôpital Lyon Sud; CHU Lyon; Pierre-Bénite France

7. UMR CNRS 5558 Evaluation et Modelisation des Effets Therapeutiques; Université Claude Bernard Lyon 1; Lyon France

8. Inserm CIE1408; F-CRIN INNOVTE Network; Paris France

9. Department of Medicine, Thrombosis and Atherosclerosis Research Institute; McMaster University; Hamilton Ontario Canada

10. Hopital Européen Georges Pompidou; APHP; Université Paris Descartes, Sorbonne Paris Cité; INSERM UMRs 970; CIE1418; F-CRIN INNOVTE Network; Paris France

Funder

Programme Hospitalier de Recherche Clinique 2008

Ministère de la Santé, France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13740/fullpdf

Reference35 articles.

1. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism;Büller;N Engl J Med,2003

2. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH;Kaatz;J Thromb Haemost,2015